Anthony Cunningham

Further development of interferon/CAR T cell therapy as a novel ‘shock and kill’ strategy to eliminate the latent HIV reservoir in CD4 T cells

Development of dual specific CAR T cell therapy after Interferon alpha pretreatment to eliminate the latent HIV-CD4 T cell reservoir

Novel diagnostics for evaluating duration of immunity after COVID-19 and for Phase I/II vaccine trials

A novel strategy for eradication of HIV using a combination of interferon activation of latently infected CD4 T cells and their targeting by TanCAR T cells

VIIM Collaborative: Clinical and immunological responses to COVID-19 vaccine(s) in NSW recipients